December 4, 1998

Berkeley Joins Swiss Company in Controversial Technology-Transfer Pact

By GOLDIE BLUMENSTYK

Despite objections from within and outside the institution, the University of California at Berkeley has signed a five-year, $25-million research deal with a giant Swiss biotechnology company, Novartis.

Under the agreement, Novartis will provide money to the university's department of plant and microbial biology in return for a first crack at commercializing the department's research findings.

Critics

Print Subscription

Digital Subscription

Already have an account? Log In Now.